About Our Company
Peptimmune is a clinical stage biotechnology company developing peptide and peptide-copolymer therapeutics for the treatment of CNS and Autoimmune disorders. These therapies target MHC Class II molecules and modulating immune responses. Founded in 2002 and located in Cambridge, MA USA, the Company is led by an experienced management team and exploits its proprietary DEEP™ Technology to design peptides and peptide mixtures.
Meet Our Team
Allyson Masci
Research Associate
Allyson Masci joined Peptimmune in 2006 as a summer intern working in the pharmacology/immunology group while completing her BS from Northeastern University. Since graduation, Allyson has been continuing her work in the…
